Standout Papers

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer 2016 2026 2019 2022 6.9k
  1. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer (2016)
    Martin Reck, Delvys Rodríguez‐Abreu et al. New England Journal of Medicine
  2. Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater (2019)
    Martin Reck, Delvys Rodríguez‐Abreu et al. Journal of Clinical Oncology
  3. Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50% (2021)
    Martin Reck, Delvys Rodríguez‐Abreu et al. Journal of Clinical Oncology
  4. Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC (2019)
    Jhanelle E. Gray, Augusto Villegas et al. Journal of Thoracic Oncology
  5. Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522 (2024)
    Lajos Pusztai, Carsten Denkert et al. Annals of Oncology

Immediate Impact

3 by Nobel laureates 7 from Science/Nature 85 standout
Sub-graph 1 of 18

Citing Papers

Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
2025 Standout
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
2023 Standout
4 intermediate papers

Works of Rina Hui being referenced

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Safety and clinical activity of MK-3475 as initial therapy in patients with advanced non-small cell lung cancer (NSCLC).
2014
and 1 more

Author Peers

Author Last Decade Papers Cites
Rina Hui 11054 7176 1871 2387 169 13.8k
Scott Gettinger 9980 6665 1688 2654 255 12.8k
Edward B. Garon 10814 7641 2051 2513 326 14.3k
Gilberto de Castro 7823 5286 1747 1316 212 10.4k
Laura Q.M. Chow 8861 4544 1594 2951 156 12.1k
Carlos H. Barrios 10539 6945 4268 1970 265 15.5k
Geoffrey R. Weiss 7763 4353 1438 2435 191 12.3k
Maya Gottfried 10411 7572 1690 1924 155 12.9k
Katsuyuki Hotta 10920 8489 1691 1916 286 13.7k
William L. Dahut 5115 4224 1583 2798 288 10.1k
Igor Bondarenko 12964 8783 3459 1823 303 17.1k

All Works

Loading papers...

Rankless by CCL
2026